US Stock MarketDetailed Quotes

WOK WORK Medical Technology

Watchlist
  • 0.520
  • -0.049-8.53%
Trading Mar 28 14:57 ET
7.59MMarket Cap-2.18P/E (TTM)

WORK Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(FY)Sep 30, 2023
(FY)Sep 30, 2022
(FY)Sep 30, 2021
(FY)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-200.83%-2.23M
197.82%2.21M
68.53%-2.26M
-126.39%-7.18M
27.2M
Net income from continuing operations
-5,685.74%-3.54M
-93.29%63.38K
-84.93%944.13K
413.70%6.27M
--1.22M
Operating gains losses
425.45%42.5K
174.41%8.09K
---10.87K
----
----
Depreciation and amortization
-12.02%1.41M
-50.80%1.6M
-22.30%3.26M
32.67%4.19M
--3.16M
Deferred tax
51.29%-46.04K
69.89%-94.53K
-170.82%-314.01K
-203.17%-115.95K
--112.38K
Change In working capital
-123.28%-107.51K
106.48%461.85K
60.75%-7.13M
-200.20%-18.16M
--18.13M
-Change in receivables
1,475.79%1.82M
96.67%-131.95K
-3,269.94%-3.96M
27.83%-117.48K
---162.79K
-Change in inventory
493.66%1.58M
-119.50%-400.54K
-70.17%2.05M
169.38%6.89M
---9.92M
-Change in prepaid assets
-133.84%-767.64K
687.85%2.27M
-103.63%-385.89K
184.86%10.63M
---12.52M
-Change in payables and accrued expense
-260.96%-4.33M
155.75%2.69M
-95.77%-4.82M
-125.53%-2.46M
--9.65M
-Change in other current liabilities
96.08%-2.03K
-893.00%-51.76K
---5.21K
--0
----
-Change in other working capital
140.87%1.6M
-49,511.06%-3.91M
99.98%-7.89K
-206.46%-33.09M
--31.08M
Cash from discontinued investing activities
Operating cash flow
-200.83%-2.23M
197.82%2.21M
68.53%-2.26M
-126.39%-7.18M
--27.2M
Investing cash flow
Cash flow from continuing investing activities
-1,453.92%-9.06M
56.70%-583.3K
-2,145.24%-1.35M
99.64%-60K
-16.84M
Net PPE purchase and sale
-1,883.08%-9.03M
67.72%-455.39K
-2,251.27%-1.41M
99.64%-60K
---16.84M
Net intangibles purchase and sale
73.96%-33.31K
---127.91K
--0
----
----
Net business purchase and sale
--0
--0
--63.62K
--0
----
Cash from discontinued investing activities
Investing cash flow
-1,453.92%-9.06M
56.70%-583.3K
-2,145.24%-1.35M
99.64%-60K
---16.84M
Financing cash flow
Cash flow from continuing financing activities
2,248.57%15.66M
-120.43%-728.72K
-55.37%3.57M
177.70%7.99M
-10.28M
Net issuance payments of debt
119.99%1.05M
45.70%-5.26M
-531.88%-9.69M
129.29%2.24M
---7.66M
Net common stock issuance
--7.37M
--0
--0
----
----
Net other financing activities
59.44%7.23M
-65.80%4.54M
130.76%13.26M
319.33%5.75M
---2.62M
Cash from discontinued financing activities
Financing cash flow
2,248.57%15.66M
-120.43%-728.72K
-55.37%3.57M
177.70%7.99M
---10.28M
Net cash flow
Beginning cash position
111.69%1.64M
-11.42%773.42K
335.69%873.13K
-21.09%200.4K
--253.95K
Current changes in cash
386.22%4.36M
2,350.47%897.71K
-105.30%-39.89K
908.62%752.97K
--74.65K
Effect of exchange rate changes
1,740.86%555.46K
43.41%-33.85K
25.45%-59.82K
37.41%-80.24K
---128.21K
End cash Position
300.52%6.56M
111.69%1.64M
-11.42%773.42K
335.69%873.13K
--200.4K
Free cash flow
-806.24%-11.49M
138.08%1.63M
40.99%-4.27M
-175.02%-7.24M
--9.65M
Currency Unit
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2024(FY)Sep 30, 2023(FY)Sep 30, 2022(FY)Sep 30, 2021(FY)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -200.83%-2.23M197.82%2.21M68.53%-2.26M-126.39%-7.18M27.2M
Net income from continuing operations -5,685.74%-3.54M-93.29%63.38K-84.93%944.13K413.70%6.27M--1.22M
Operating gains losses 425.45%42.5K174.41%8.09K---10.87K--------
Depreciation and amortization -12.02%1.41M-50.80%1.6M-22.30%3.26M32.67%4.19M--3.16M
Deferred tax 51.29%-46.04K69.89%-94.53K-170.82%-314.01K-203.17%-115.95K--112.38K
Change In working capital -123.28%-107.51K106.48%461.85K60.75%-7.13M-200.20%-18.16M--18.13M
-Change in receivables 1,475.79%1.82M96.67%-131.95K-3,269.94%-3.96M27.83%-117.48K---162.79K
-Change in inventory 493.66%1.58M-119.50%-400.54K-70.17%2.05M169.38%6.89M---9.92M
-Change in prepaid assets -133.84%-767.64K687.85%2.27M-103.63%-385.89K184.86%10.63M---12.52M
-Change in payables and accrued expense -260.96%-4.33M155.75%2.69M-95.77%-4.82M-125.53%-2.46M--9.65M
-Change in other current liabilities 96.08%-2.03K-893.00%-51.76K---5.21K--0----
-Change in other working capital 140.87%1.6M-49,511.06%-3.91M99.98%-7.89K-206.46%-33.09M--31.08M
Cash from discontinued investing activities
Operating cash flow -200.83%-2.23M197.82%2.21M68.53%-2.26M-126.39%-7.18M--27.2M
Investing cash flow
Cash flow from continuing investing activities -1,453.92%-9.06M56.70%-583.3K-2,145.24%-1.35M99.64%-60K-16.84M
Net PPE purchase and sale -1,883.08%-9.03M67.72%-455.39K-2,251.27%-1.41M99.64%-60K---16.84M
Net intangibles purchase and sale 73.96%-33.31K---127.91K--0--------
Net business purchase and sale --0--0--63.62K--0----
Cash from discontinued investing activities
Investing cash flow -1,453.92%-9.06M56.70%-583.3K-2,145.24%-1.35M99.64%-60K---16.84M
Financing cash flow
Cash flow from continuing financing activities 2,248.57%15.66M-120.43%-728.72K-55.37%3.57M177.70%7.99M-10.28M
Net issuance payments of debt 119.99%1.05M45.70%-5.26M-531.88%-9.69M129.29%2.24M---7.66M
Net common stock issuance --7.37M--0--0--------
Net other financing activities 59.44%7.23M-65.80%4.54M130.76%13.26M319.33%5.75M---2.62M
Cash from discontinued financing activities
Financing cash flow 2,248.57%15.66M-120.43%-728.72K-55.37%3.57M177.70%7.99M---10.28M
Net cash flow
Beginning cash position 111.69%1.64M-11.42%773.42K335.69%873.13K-21.09%200.4K--253.95K
Current changes in cash 386.22%4.36M2,350.47%897.71K-105.30%-39.89K908.62%752.97K--74.65K
Effect of exchange rate changes 1,740.86%555.46K43.41%-33.85K25.45%-59.82K37.41%-80.24K---128.21K
End cash Position 300.52%6.56M111.69%1.64M-11.42%773.42K335.69%873.13K--200.4K
Free cash flow -806.24%-11.49M138.08%1.63M40.99%-4.27M-175.02%-7.24M--9.65M
Currency Unit USDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Shenzhen Kaifa Technology
920029
+150.36%
Shanghai Yongli Belting
300230
+20.04%
Guomai Culture & Media
301052
+20.00%
4
WuHan Hvsen Biotechnology
300871
+19.05%
5
CHANGFU CO.,LTD
871396
+18.10%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings